• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever.风湿热二级预防用药依从率及影响因素分析。
J Paediatr Child Health. 2021 Mar;57(3):419-424. doi: 10.1111/jpc.15239. Epub 2020 Dec 19.
2
Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.年轻人风湿热和风湿性心脏病二级预防的依从性:一项11年的回顾性研究。
Aust N Z J Public Health. 2022 Dec;46(6):758-763. doi: 10.1111/1753-6405.13250. Epub 2022 May 26.
3
Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.在穆拉戈医院就诊的风湿性心脏病患者中,苄星青霉素用于二级预防的依从性。
Cardiovasc J Afr. 2013 May;24(4):124-9. doi: 10.5830/CVJA-2013-022.
4
Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.采用以基层医疗中心为基础的持续质量改进方法改善风湿热和风湿性心脏病的管理和预防。
BMC Health Serv Res. 2013 Dec 18;13:525. doi: 10.1186/1472-6963-13-525.
5
Priorities for improved management of acute rheumatic fever and rheumatic heart disease: analysis of cross-sectional continuous quality improvement data in Aboriginal primary healthcare centres in Australia.改善急性风湿热和风湿性心脏病管理的重点:澳大利亚原住民初级保健中心横断面连续质量改进数据的分析。
Aust Health Rev. 2020 Apr;44(2):212-221. doi: 10.1071/AH19132.
6
Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.分享成功经验——了解风湿热和风湿性心脏病二级预防实施的障碍与促进因素。
BMC Cardiovasc Disord. 2016 Aug 31;16(1):166. doi: 10.1186/s12872-016-0344-x.
7
Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.埃塞俄比亚风湿性心脏病的二级预防:一项多中心研究。
BMC Cardiovasc Disord. 2022 Feb 2;22(1):26. doi: 10.1186/s12872-022-02473-4.
8
Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory.急性风湿热:北领地凯瑟琳地区原住民患者二级预防的依从性及随访情况
Aust J Rural Health. 2007 Aug;15(4):234-40. doi: 10.1111/j.1440-1584.2007.00896.x.
9
Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia.澳大利亚北领地风湿性心脏病土著儿童和青年人群中苄星青霉素 G 给药的群体药代动力学研究。
J Antimicrob Chemother. 2022 Sep 30;77(10):2679-2682. doi: 10.1093/jac/dkac231.
10
Effect of secondary penicillin prophylaxis on valvular changes in patients with rheumatic heart disease in Far North Queensland.二次青霉素预防对昆士兰远北地区风湿性心脏病患者瓣膜变化的影响。
Aust J Rural Health. 2018 Apr;26(2):119-125. doi: 10.1111/ajr.12379. Epub 2017 Nov 23.

引用本文的文献

1
Comparison of mortality trends in patients with rheumatic mitral valve disease and nonrheumatic mitral valve disease: A retrospective study in US from 1999 to 2020.风湿性二尖瓣疾病与非风湿性二尖瓣疾病患者死亡率趋势比较:一项1999年至2020年美国的回顾性研究。
Int J Cardiol Heart Vasc. 2025 Apr 24;59:101687. doi: 10.1016/j.ijcha.2025.101687. eCollection 2025 Aug.
2
Severe adverse reactions to benzathine penicillin G in rheumatic heart disease: A systematic review and meta-analysis.风湿性心脏病患者对苄星青霉素G的严重不良反应:一项系统评价和荟萃分析。
PLoS One. 2025 May 7;20(5):e0322873. doi: 10.1371/journal.pone.0322873. eCollection 2025.
3
Barriers and facilitators of benzathine penicillin G adherence among rheumatic heart disease patients: a mixed methods systematic review using the COM-B (capability, opportunity, and motivation for behavior) model.风湿性心脏病患者苄星青霉素G依从性的障碍与促进因素:一项使用COM-B(行为能力、机会和动机)模型的混合方法系统评价
Syst Rev. 2024 Dec 3;13(1):297. doi: 10.1186/s13643-024-02691-1.
4
Adherence to secondary antibiotic prophylaxis among patients with acute rheumatic fever and/or rheumatic heart disease: a systematic review and meta-analysis.急性风湿热和/或风湿性心脏病患者二级抗生素预防的依从性:系统评价和荟萃分析。
BMJ Open. 2024 Nov 14;14(11):e082191. doi: 10.1136/bmjopen-2023-082191.
5
Socio-economic determinants influencing adherence to secondary prophylaxis in patients with rheumatic heart disease: a systematic review.影响风湿性心脏病患者二级预防依从性的社会经济决定因素:一项系统综述
Ann Med Surg (Lond). 2024 May 17;86(7):4092-4097. doi: 10.1097/MS9.0000000000002164. eCollection 2024 Jul.
6
Patient preferences for prophylactic regimens requiring regular injections in children and adolescents: a systematic review and thematic analysis.患者对儿童和青少年需要定期注射的预防方案的偏好:系统评价和主题分析。
BMJ Paediatr Open. 2024 May 20;8(1):e002450. doi: 10.1136/bmjpo-2023-002450.
7
Treatment adherence and its determinants among the rheumatic fever/rheumatic heart disease patients during COVID 19 pandemic - A cross sectional study from Chandigarh, India.COVID-19大流行期间风湿热/风湿性心脏病患者的治疗依从性及其决定因素——来自印度昌迪加尔的横断面研究
J Family Med Prim Care. 2023 Dec;12(12):3254-3261. doi: 10.4103/jfmpc.jfmpc_941_23. Epub 2023 Dec 21.
8
Secondary Prophylaxis Among First Nations People With Acute Rheumatic Fever in Australia: An Integrative Review.澳大利亚原住民中急性风湿热的二级预防:综合评价。
J Transcult Nurs. 2023 Nov;34(6):443-452. doi: 10.1177/10436596231191248. Epub 2023 Aug 12.
9
The rise and fall of acute rheumatic fever and rheumatic heart disease: a mini review.急性风湿热和风湿性心脏病的兴衰:一篇综述短文
Front Cardiovasc Med. 2023 May 23;10:1183606. doi: 10.3389/fcvm.2023.1183606. eCollection 2023.

本文引用的文献

1
The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease.2020 年澳大利亚急性风湿热和风湿性心脏病预防、诊断和管理指南。
Med J Aust. 2021 Mar;214(5):220-227. doi: 10.5694/mja2.50851. Epub 2020 Nov 15.
2
Priorities for improved management of acute rheumatic fever and rheumatic heart disease: analysis of cross-sectional continuous quality improvement data in Aboriginal primary healthcare centres in Australia.改善急性风湿热和风湿性心脏病管理的重点:澳大利亚原住民初级保健中心横断面连续质量改进数据的分析。
Aust Health Rev. 2020 Apr;44(2):212-221. doi: 10.1071/AH19132.
3
More than a refresh required for closing the gap of Indigenous health inequality.缩小原住民健康不平等差距所需的远不止一次革新。
Med J Aust. 2020 Mar;212(5):198-199.e1. doi: 10.5694/mja2.50498. Epub 2020 Feb 6.
4
How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.多少剂量有差异?风湿热和风湿性心脏病二级预防的分析。
J Am Heart Assoc. 2018 Dec 18;7(24):e010223. doi: 10.1161/JAHA.118.010223.
5
Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.在高负担环境下改善风湿性心脏病二级预防的提供:一项阶梯式、社区、随机试验的结果。
J Am Heart Assoc. 2018 Jul 17;7(14):e009308. doi: 10.1161/JAHA.118.009308.
6
Effect of secondary penicillin prophylaxis on valvular changes in patients with rheumatic heart disease in Far North Queensland.二次青霉素预防对昆士兰远北地区风湿性心脏病患者瓣膜变化的影响。
Aust J Rural Health. 2018 Apr;26(2):119-125. doi: 10.1111/ajr.12379. Epub 2017 Nov 23.
7
Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data.登记数据低估了风湿性心脏病二级预防的依从性。
PLoS One. 2017 May 31;12(5):e0178264. doi: 10.1371/journal.pone.0178264. eCollection 2017.
8
Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review.急性风湿热和风湿性心脏病二级预防的依从性:一项系统评价。
Curr Cardiol Rev. 2017;13(2):155-166. doi: 10.2174/1573403X13666170116120828.
9
Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji.斐济通过筛查诊断出的风湿性心脏病患者对二级抗生素预防的依从性。
Trop Med Int Health. 2016 Dec;21(12):1583-1591. doi: 10.1111/tmi.12796. Epub 2016 Oct 28.
10
Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.采用以基层医疗中心为基础的持续质量改进方法改善风湿热和风湿性心脏病的管理和预防。
BMC Health Serv Res. 2013 Dec 18;13:525. doi: 10.1186/1472-6963-13-525.

风湿热二级预防用药依从率及影响因素分析。

Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever.

机构信息

College of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia.

Clinical Services, Apunipima Cape York Health Council, Cairns, Queensland, Australia.

出版信息

J Paediatr Child Health. 2021 Mar;57(3):419-424. doi: 10.1111/jpc.15239. Epub 2020 Dec 19.

DOI:10.1111/jpc.15239
PMID:33340191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8048926/
Abstract

AIM

Secondary prophylaxis with 3-4 weekly benzathine penicillin G injections is necessary to prevent disease morbidity and cardiac mortality in patients with acute rheumatic fever (ARF) and rheumatic heart disease (RHD). This study aimed to determine secondary prophylaxis adherence rates in the Far North Queensland paediatric population and to identify factors contributing to suboptimal adherence.

METHODS

A retrospective analysis of data recorded in the online RHD register for Queensland, Australia, was performed for a 10-year study period. The proportion of benzathine penicillin G injections delivered within intervals of ≤28 days and ≤35 days was measured. A multi-level mixed model logistic regression assessed the influence of age, gender, ethnicity, suburb, Accessibility and Remoteness Index of Australia class, number of people per dwelling, Index of Relative Socio-economic Advantage and Disadvantage, Index of Education and Occupation, year of inclusion on an ARF/RHD register and individual effect.

RESULTS

The study included 277 children and analysis of 7374 injections. No children received ≥80% of recommended injections within a 28-day interval. Four percent received ≥50% of injections within ≤28 days and 46% received ≥50% of injections at an extended interval of ≤35 days. Increasing age was associated with reduced delivery of injections within 35 days. Increasing year of inclusion was associated with improved delivery within 28 days. The random effect of individual patients was significantly associated with adherence.

CONCLUSIONS

Improved timely delivery of secondary prophylaxis for ARF and RHD is needed as current adherence is very low. Interventions should focus on factors specific to each individual child or family unit.

摘要

目的

对于急性风湿热(ARF)和风湿性心脏病(RHD)患者,需要每 3-4 周进行苄星青霉素 G 肌内注射进行二级预防,以预防疾病发病和心脏死亡。本研究旨在确定北昆士兰儿科人群的二级预防依从率,并确定导致依从性不佳的因素。

方法

对澳大利亚昆士兰州 RHD 在线注册数据库进行了为期 10 年的回顾性数据分析。测量了在≤28 天和≤35 天的间隔内注射苄星青霉素 G 的比例。多水平混合模型逻辑回归评估了年龄、性别、种族、郊区、澳大利亚可达性和偏远指数分类、每户人数、相对社会经济优势和劣势指数、教育和职业指数、纳入 ARF/RHD 登记册的年份以及个体效应等因素对青霉素 G 注射的影响。

结果

研究纳入了 277 名儿童,分析了 7374 次注射。没有儿童在 28 天的间隔内接受了≥80%的推荐注射。4%的儿童在≤28 天内接受了≥50%的注射,46%的儿童在≤35 天的延长间隔内接受了≥50%的注射。年龄增加与 35 天内注射次数减少有关。纳入年份的增加与 28 天内注射次数的增加有关。个体患者的随机效应与依从性显著相关。

结论

需要改善 ARF 和 RHD 的二级预防及时给药,因为目前的依从率非常低。干预措施应针对每个儿童或家庭单位的具体因素。